Development of an Endothelial Cell Seeded Device  by ter Meer, M. et al.
European Journal of Vascular and Endovascular Surgery Volume 47 Issue 6 p. 689e698 June/2014 691ionizing radiation (LDIR) induce angiogenesis in vivo by
activating the receptor 2 of VEGF but, there is no evidence
that it enhances neovascularization in vascular occlusive
disease, our overall objective.
Methods: We used a mouse model of hind-limb ischemia.
In 22-wk-old C57BL/6 mice, the distal external iliac and
femoral arteries and veins were ligated and excised. After
that, the mice were irradiated or not with 0.3 Gy using a
linear accelerator x-rays photon beam. The laser-Doppler
perfusion imager (MoorLD2-V5.x, Moor Instruments Ltd,
Axminster, UK) was used to assess limb perfusion. Blood
ﬂow was measured both in the ischemic and contralateral
leg preoperatively, immediately postoperatively and at
post-operative day 7 and day 15. Collateral vessels were
evaluated by diaphanization. Capillaries were identiﬁed by
CD31 immunohistochemistry and myocytes were coun-
terstained with haematoxylin. In order to identify the
molecular targets involved in the pro-angiogenic pheno-
type promoted by LDIR, endothelial cells from gastrocne-
mius muscle sections were isolated by a Laser Capture
Microdissection microscope followed by RNA extraction,
cDNA synthesis, pre-ampliﬁcation and qRT-PCR analysis.
Results: A signiﬁcant increment in perfusion in the irradi-
ated mice when compared to the unirradiated ones (p ¼
0.00075) was found by laser Doppler at 15 days post-
ischemia. Accordingly, a statistically signiﬁcant increase in
collateral development (p ¼ 0.0198) and in capillary density
(p ¼ 0.00009) was noted in irradiated mice. Interestingly, in
the absence of the ischemia injury, similar capillary/myocyte
ratios were found in unirradiated and irradiated gastroc-
nemius muscles. From an in vitro microarray data obtained
in our lab, we selected the genes whose expression is
signiﬁcantly altered by low doses of IR and that represent
the best candidates for a pro-angiogenic response. Their
expression was evaluated in endothelial cells isolated from
the gastrocnemius muscles from irradiated and unirradiated
mice by using a laser capture microdissection microscope
followed by RNA extraction and cDNA synthesis. Several
pro-angiogenic genes were pre-ampliﬁed before quantita-
tive RT-PCR analyses. Our results suggest that low-dose IR
induces simultaneously the expression of VERGR1, VEGFR2,
FGF2, TGFB2, ANG2, PDGFC, HGF and c-met in endothelial
cells isolated from ischemic muscles.
Conclusion: The outcome of these experiments performed
in a mice model suggests that LDIR may have clinical use in
the treatment of lower limb vascular insufﬁciency.Development of an Endothelial Cell Seeded Device
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Introduction: Endovascular interventions result in extensive
endothelial cell (EC) damage, an inﬂammatory response and
subsequent active stimulation of smooth muscle cellproliferation. These factors combined will lead to intimal
hyperplasia and eventually restenosis. EC recovery is essen-
tial in restoring vessel function and preventing intimal hy-
perplasia. A complete and functional EC lining will inhibit
smooth muscle cell proliferation thereby limiting thrombosis
and arterial wall remodelling. Repair of the EC lining is a very
slow process in humans. We aim to rapidly restore the EC
lining after vascular interventions using autologous ECs
combined with biomaterials minimally invasively. Although
use of autologous ECs does not allow off-the-shelf use of this
product, we believe the non-immunogenic nature of the cells
provides major advantages.
Methods: In order to establish fast and complete EC coverage
after vascular intervention a carrier suitable for endothelial
cell incorporation was developed. ECs were isolated from
human veins of 14 donors, and cultured in-vitro using EGM-2
(Lonza) medium. EC phenotype was conﬁrmed using ﬂuo-
rescently labelled anti-CD31 and anti-vWF. Culture protocols
were optimized to speed up the culture process, cell seeding
efﬁciency and surface characteristics of the biomaterials
were optimized as well. Blood endothelial progenitor cells
(EPCs) were explored as an alternative cellular source, using 3
human donors. An in-vitro tubular ﬂow chamber was used to
determine the inﬂuence of physiological ﬂow conditions on
cellular attachment and function.
Results: The EC seeding efﬁciency onto the biomaterial was
optimized, a minimum number of harvested cells is sufﬁcient
to completely cover the biomaterial surface. In addition we
were able to produce twice the number of cells in the same
timeframe. Therefore low passage numbers can be used and
cells are available faster, which is very beneﬁcial in a clinical
setting. The cell isolation method was robust and reproduc-
ible. Cells attached to the cleaned and sterilized biomaterial
within a period of 24 hours. Once the cell seeded biomaterial
was placed on a polystyrene cell culture surface the cells
proliferated and migrated away from the biomaterial within
several days. The in-vitro ﬂow experiments showed that cells
attached to the biomaterial remained attached under physi-
ological ﬂow conditions.
Conclusion: A biomaterial was developed and tested as a
carrier for endothelial cells. The cell seeded material may
provide a means to re-endothelialise a damaged vessel wall
within a matter of days with prevention of intimal hyper-
plasia. In-vivo animal experiments are currently performed
to conﬁrm this hypothesis.
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Introduction: The generation of bioartiﬁcial small calibre
vascular segments is an ongoing challenge in vascular tissue
engineering. Whereas ﬁbrin preparations have been proven
